CXCL14 and coronary artery disorder: The current investigation revealed that (1) the CXCL14 platelet surface association was higher in patients with ACS and patients without CAD when compared with those with CCS; (2) both platelet-associated and circulating CXCL14 levels differed in patients with normal vs impaired baseline systolic LVEF; and (3) only low circulating CXCL14 (first quartile) may be associated with worse outcomes in patients with CAD, whereas there were no relevant correlations for platelet-associated CXCL14 [5].